Similar Items: MEK inhibitors for neurofibromatosis type 1-associated central and peripheral nervous system tumors
- The future of targeted therapies for pediatric central nervous system tumors
- Targeted therapies in adolescent and young adult patients with central nervous system tumors
- Effects of physical exercise on central nervous system functions: a review of brain region specific adaptations
- FGFR alterations and potential role of FGFR inhibitors in pediatric brain tumors
- Toxic Effects of Excess Vitamins A, B6, and Folic Acid on the Nervous System
- Peripheral Blood Regulatory T Cells and IL-6 are Associated with Cognitive Impairment After Acute Ischemic Stroke